Posted on 2/9/2023
On March 21, 2022, Betta Pharmaceuticals Co., Ltd. received the "Drug Registration Certificate" issued by the State Drug Administration
NMPA Approval
March 21, 2022 Ensartinib (first-line treatment for lung cancer)
On March 21, 2022, Betta Pharmaceuticals Co., Ltd. received the "Drug Registration Certificate" issued by the State Drug Administration (drug approval number: GUO XIE ZHU ZHUN H20200009, GUO YAO ZHUN ZI H20200010), Ensartinib. hydrochloride capsule has been approved for marketing as a new in...